First Wave BioPharma Inc (FWBI) stock has fallen -94.35% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives FWBI stock a score of 33 out of a possible 100.
That rank is mainly influenced by a long-term technical score of 2. FWBI's rank also includes a short-term technical score of 3. FWBI has an Overall Score of 33. Find out what this means to you and get the rest of the rankings on FWBI!